0.34 - 0.34
0.23 - 0.41
110.0K / 51.2K (Avg.)
-1.33 | -0.26
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-49.38%
Negative revenue growth while PONY stands at 53.48%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-41.91%
Negative gross profit growth while PONY is at 49.53%. Joel Greenblatt would examine cost competitiveness or demand decline.
-44.61%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-44.57%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
-31.13%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-32.88%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-32.88%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
2.69%
Share count expansion well above PONY's 4.32%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.
2.69%
Diluted share count expanding well above PONY's 4.32%. Michael Burry would fear significant dilution to existing owners' stakes.
No Data
No Data available this quarter, please select a different quarter.
-168.83%
Negative OCF growth while PONY is at 0.00%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-181.77%
Negative FCF growth while PONY is at 0.00%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
-1.42%
Both companies have negative long-term revenue/share growth. Martin Whitman would question if the entire market or product set is shrinking.
-1.42%
Both face negative 5Y revenue/share CAGR. Martin Whitman would suspect macro headwinds or obsolete product offerings across the niche.
-1.42%
Both firms have negative 3Y CAGR. Martin Whitman would wonder if the entire market segment is in short-term retreat.
-234.05%
Negative 10Y OCF/share CAGR while PONY stands at 0.00%. Joel Greenblatt would scrutinize managerial effectiveness and product competitiveness.
-234.05%
Negative 5Y OCF/share CAGR while PONY is at 0.00%. Joel Greenblatt would question the firm’s operational model or cost structure.
-234.05%
Negative 3Y OCF/share CAGR while PONY stands at 0.00%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
34.13%
Net income/share CAGR at 50-75% of PONY's 63.21%. Martin Whitman might question if the firm’s product or cost base lags behind.
34.13%
5Y net income/share CAGR at 50-75% of PONY's 63.21%. Martin Whitman might see a shortfall in operational efficiency or brand power.
34.13%
3Y net income/share CAGR 50-75% of PONY's 63.21%. Martin Whitman might see a lagging edge in short-term profitability vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-40.83%
We cut SG&A while PONY invests at 44.40%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.